US 8809335
Pyrazolopyrimidine kinase inhibitors
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8809335 (Pyrazolopyrimidine kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/16, A61P11/00